The NDUFA11 gene gives cells instructions for part of complex I, a structure in mitochondria that helps turn food into usable energy. This gene plays an important role in tissues with high energy needs, such as the brain, muscles, and heart. If NDUFA11 is not working properly, cells may make less energy, which can lead to mitochondrial disease with symptoms like muscle weakness, developmental delay, seizures, or heart problems. Most people hear about the NDUFA11 gene through genetic testing rather than public news stories.
What is a gene?
Genes are stretches of DNA that hold instructions cells use to make molecules or manage processes throughout the body. Some genes provide the directions for making proteins, which do much of the work inside cells. Others mainly regulate when certain processes happen, where they happen, and how active they are. Taken together, genes affect how the body grows and works, and they can influence how you respond to food, stress, or medications. For a more detailed look at this topic, you can find additional information in the LearnHub.
Overview
NDUFA11Gene function
What if the gene works
The NDUFA11 gene helps build part of complex I, a key energy making system in mitochondria, the cell’s energy centers. This supports steady energy production, especially in the brain, heart, and muscles.
Risk
What if the gene does not work
More disruptive variants in the NDUFA11 gene can reduce the cell’s energy production and may cause mitochondrial complex I deficiency. Symptoms often affect the brain and muscles, ranging from early severe neurologic disease to milder later-onset problems.
Treatment
What does that mean for your treatment
No NDUFA11-specific treatment or drug selection approach is currently established in clinical guidelines; care is based on the person’s symptoms and the broader management of mitochondrial disease.
Conditions associated with NDUFA11
Gene function
What if the gene works
Your cells need a steady power supply to do everyday work. The NDUFA11 gene helps with an early step in how your cells turn food into usable energy. It does this inside mitochondria, the parts of cells that act as energy centers. This steady support is especially important in tissues that use a lot of energy.
The protein from the NDUFA11 gene is part of complex I, a large energy making machine in mitochondria. It helps your cells begin the process that captures energy from nutrients and passes it along for usable cell energy.
NDUFA11 helps keep complex I properly built and steady within the inner mitochondrial membrane, the layer where much of cell energy production happens. This support lets the larger complex work in an organized way.
As part of complex I, it supports the movement of electrons, tiny charged particles used in energy production. This is an early step in the process that helps mitochondria release usable energy for the cell.
Complex I helps create a difference in charge across the mitochondrial membrane, a stored form of energy your cells can use. NDUFA11 supports this by helping the complex stay in the right place and shape.
What is a variant?
A genetic variant is a small difference in the DNA sequence of a gene. These differences are common and help account for normal human diversity, such as variation in appearance, metabolism, or how the body responds to environmental influences. Many variants do not lead to any noticeable effect and are simply part of natural genetic variation. In some situations, however, a variant can change a gene’s function more significantly and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the NDUFA11 gene often make the protein unstable or prevent it from fitting properly into mitochondrial complex I, the first step in the cell’s energy-making chain. These NDUFA11 gene variants can weaken complex assembly, lower energy production, and in some cells increase harmful oxygen byproducts. Milder variants may leave some activity in place, while more severe variants can cause little or no working protein and are more often linked to earlier or more pronounced mitochondrial disease.
How variants are linked to conditions
Pathogenic variants in the NDUFA11 gene are linked to mitochondrial complex I deficiency, a rare inherited mitochondrial disease. Some people with this diagnosis develop developmental delay, lactic acidosis, seizures, brain changes consistent with Leigh syndrome, or cardiomyopathy. Because this is a rare monogenic condition, finding pathogenic variants in both copies of the NDUFA11 gene can confirm the diagnosis.
A variant is not necessarily a diagnosis
Genetic variants are a normal feature of human biology and are common across the general population. Most do not have a direct impact on health and simply reflect natural human variation. For many genes, carrying a variant associated with a condition suggests a possible link rather than a definite diagnosis, especially when several genes and environmental factors also contribute. In some situations, though, a single well-characterized variant in a specific gene can be enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There isn't yet broadly confirmed evidence on specific factors that increase or reduce risk related to the NDUFA11 gene. If a disease-causing change is present, risk is mostly shaped by that inherited change, and a doctor or genetic counselor can help explain what it may mean for you or your family.
Inheritance of NDUFA11 variants
NDUFA11 inheritance is usually autosomal recessive for the conditions linked to this gene. This means a child typically inherits one NDUFA11 variant from each parent, and the parents are often healthy carriers. When both parents carry a variant in the NDUFA11 gene, each pregnancy has a 25% chance of the child inheriting both altered copies, a 50% chance of being a carrier, and a 25% chance of inheriting neither variant. Sons and daughters are affected at similar rates because the NDUFA11 gene is on an autosome, not a sex chromosome.
What does my NDUFA11 result mean for my family?
For families with a disease-causing NDUFA11 result, this condition is usually passed down in a recessive pattern. That often means parents are healthy carriers, brothers and sisters may also be affected or be carriers, and some other blood relatives could carry the same change without knowing it. Family testing can help clarify who else in the family may have the variant.
Genetic information
Genetic testing
How you find out about variants
To check for changes in the NDUFA11 gene, labs use NDUFA11 genetic testing on DNA from blood, saliva, or a cheek swab. The test reads the gene’s sequence to look for variants and may be done on its own or as part of a larger gene panel or exome test.
When should I consider getting a genetic test?
Genetic testing for the NDUFA11 gene may be considered when a child or adult has signs of a condition that affects how the body's cells make energy, such as severe muscle weakness, poor growth, heart problems, seizures, or developmental delay, especially with a family history of similar illness. Testing can help show whether a change in NDUFA11 is the cause.
A genetic result is only one part of your health story
A genetic finding can provide valuable insight, but how much it reveals varies by the condition and the type of variant present. Factors such as lifestyle, environment, age, and medical history also shape how the body functions over time. For some conditions, especially those influenced by many genes, genetic information provides context rather than certainty and is best understood together with other aspects of care. In other situations, a genetic result can offer a clear answer. In areas like medication response, it can help place individual experiences in context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how your body handles certain medicines, which helps explain why the same treatment can work well for one person but less well for another. Some people break down a drug more slowly or more quickly, while others may be more or less sensitive to its effects. These differences are common and can influence how well a medicine works or the chance of side effects.
What is Pharmacogenetics?
Pharmacogenetics is the area of study that looks at how genetic differences affect the response to medications. By examining the relationship between genes and drugs, it helps explain why treatment can work differently from one person to another. For many medicines, genes influence both how the body processes a drug and how strong its effects may be. This information can support more informed, more individualized treatment decisions. To explore this topic further, you can learn more in the LearnHub.
Drugs influenced by the NDUFA11 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding how medicines are chosen or used, so any questions about treatments, side effects, or your health are best discussed with your doctor.
History
NDUFA11 came into view through research on mitochondrial complex I, the cell’s main system for starting energy production. Scientists first identified the protein as one of the smaller parts of this large enzyme group while mapping how complex I is built. Over time, descriptions became more precise. As DNA sequencing improved, changes in the NDUFA11 gene were linked to some inherited mitochondrial conditions, which helped connect earlier lab findings with patient care. That progress placed NDUFA11 within the broader story of how researchers learned to match individual complex I subunits to specific genetic causes of disease.